Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for improving piglet production performance and preparation method and application of medicine composition

A technology of production performance and composition, applied in the application, animal feed, additional food elements, etc., can solve the problem of small improvement, and achieve the effect of improving production performance and good application prospects

Inactive Publication Date: 2016-05-04
CHENGDU HUALUO BIOTECH CO LTD
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Cheng Zhonggang, "Effects of daidzein on piglet production performance and blood biochemical indicators", in the Journal of Henan University of Science and Technology (Agronomy Edition), Volume 23, Issue 4, December 2003, disclosed that daidzein can effectively improve piglet production performance, but the increase rate smaller

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for improving piglet production performance and preparation method and application of medicine composition
  • Medicine composition for improving piglet production performance and preparation method and application of medicine composition
  • Medicine composition for improving piglet production performance and preparation method and application of medicine composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Preparation and efficacy of embodiment 1 pharmaceutical composition of the present invention

[0033] 1. Preparation method

[0034] 1.8% daidzein, 0.1% daidzein, 0.8% genistin, 2.1% daidzein, 0.1% daidzein, 0.2% genistein, with soybean powder as the carrier.

[0035] Respectively take the crude drug (5.1%) and 94.9% bean powder (carrier) of the above weight ratios, and fully mix them uniformly.

[0036] 2. Efficacy test

[0037] Experimental group group:

[0038] The composition group of the present invention: the pharmaceutical composition of the present invention prepared by the aforementioned method.

[0039] Daidzin group: 5.1% daidzin, with soybean powder as carrier.

[0040] Daidzein group: 5.1% daidzein, with soybean powder as the carrier.

[0041] Genistin group: genistin 5.1%, with soybean powder as carrier.

[0042] The daidzein group: 5.1% daidzein, with soybean powder as the carrier.

[0043] Glyzein group: 5.1% glycitein, with soybean powder as the ...

Embodiment 2

[0054] Preparation and efficacy of embodiment 2 pharmaceutical composition of the present invention

[0055] 1. Preparation method

[0056] 2.2% daidzein, 0.2% daidzein, 1.2% genistin, 3.0% daidzein, 0.18% daidzein, 0.25% genistein, with soybean powder as the carrier. Total content: 7.13%.

[0057] Respectively take the bulk drug (7.13%) and 92.87% bean powder (carrier) by weight in the above proportions, and fully mix them uniformly.

[0058] 2. Efficacy test

[0059] Experimental group group:

[0060] The composition group of the present invention: the pharmaceutical composition of the present invention prepared by the aforementioned method.

[0061] Daidzin group: 7.13% daidzin, with soybean powder as carrier.

[0062] Genistin group: genistin 7.13%, with soybean powder as carrier.

[0063] The daidzein group: 7.13% daidzein, with soybean powder as the carrier.

[0064] Soybeanthin group: 7.13% glycitein, with soybean powder as the carrier.

[0065] Genistein group:...

Embodiment 3

[0074] Preparation and efficacy of embodiment 3 pharmaceutical composition of the present invention

[0075] 1. Preparation method

[0076] 2.6% daidzein, 0.3% daidzein, 1.5% genistin, 3.7% daidzein, 0.25% daidzein, 0.3% genistein, with soybean powder as the carrier. Total content: 8.65%. Respectively take the crude drug (8.65%) and 91.35% bean powder (carrier) of the above proportions by weight, and fully mix them uniformly.

[0077] 2. Efficacy test

[0078] Experimental group group:

[0079] The composition group of the present invention: the pharmaceutical composition of the present invention prepared by the aforementioned method.

[0080] Daidzin group: 8.65% daidzin, with soybean powder as carrier.

[0081] Genistin group: 8.65% genistin, with soybean powder as carrier.

[0082] The daidzein group: 8.65% daidzein, with soybean powder as the carrier.

[0083] Soybeanthin group: 8.65% glycitein, with soybean powder as the carrier.

[0084] Genistein group: 8.65% ge...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition for improving piglet production performance. The medicine composition consists of the following components in parts by weight: 1.8-2.6 parts of daidzin, 0.1-0.3 part of glycitin, 0.8-1.5 parts of genistin, 2.1-3.7 parts of daidzein, 0.1-0.25 part of glycitein and 0.2-0.3 part of genistein. The invention further discloses a preparation method and application of the composition. The medicine composition disclosed by the invention is good in application prospect, and the production performance of piglets can be effectively improved.

Description

technical field [0001] The invention relates to a pharmaceutical composition for improving the production performance of piglets, a preparation method and application thereof. Background technique [0002] Feed additives can improve the nutritional efficiency and production performance of livestock and poultry, so they are used in almost all production processes of various livestock and poultry. However, most of the conventional additives are chemically synthesized drugs or hormones. Continuous use will easily cause residues in animals and animal products, which will largely lead to drug resistance in livestock and poultry, and animal products with drug residues will endanger human health. , Eating it may cause cancer in humans. With the continuous improvement of living standards, human beings urgently need green and safe livestock products. Therefore, seeking safe and effective additives has become a concern of domestic and foreign experts and scholars. Chinese herbal me...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23K50/30A23K20/121
Inventor 晨光李晓斌柴世宏李延肖丽
Owner CHENGDU HUALUO BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com